Literature DB >> 19698915

Malignant melanoma.

Joseph Califano1, Melonie Nance.   

Abstract

Malignant melanoma is the most lethal cutaneous neoplasm. Awareness, detection, and treatment along with sophistication of both the physician and patient are integral components to early recognition and cure of the disease. Diagnosis of melanoma at its earliest stage is crucial to outcome. This article discusses in depth the clinical presentation and evaluation, patterns of growth, and pathologic staging of the neoplasm and regional lymph nodes. Treatment approaches and outcomes are presented.

Entities:  

Mesh：

Year:  2009        PMID： 19698915     DOI： 10.1016/j.fsc.2009.05.002

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN： 1064-7406            Impact factor:   1.918


  3 in total

1.  Phosphoproteomic screen identifies potential therapeutic targets in melanoma.

Authors:  Kathryn Tworkoski; Garima Singhal; Sebastian Szpakowski; Christina Ivins Zito; Antonella Bacchiocchi; Viswanathan Muthusamy; Marcus Bosenberg; Michael Krauthammer; Ruth Halaban; David F Stern
Journal:  Mol Cancer Res       Date:  2011-04-26       Impact factor: 5.852

2.  Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant melanoma following surgery.

Authors:  Michelle D Hackshaw; Arun Krishna; David J Mauro
Journal:  Clinicoecon Outcomes Res       Date:  2012-06-18

Review 3.  Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potential therapeutics.

Authors:  Aleksandra M Juszczak; Ute Wöelfle; Marijana Zovko Končić; Michał Tomczyk
Journal:  Med Res Rev       Date:  2022-02-21       Impact factor: 12.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.